ONCOBETA
LIVE

Serial Number

90527069

Owner

OncoBeta International GmbH

Attorney

Daniel P. Mullarkey

First Use Date

Dec 1, 2024

Filing Date

Feb 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ONCOBETA Trademark

Serial Number: 90527069 • Registration: 7787489

ONCOBETA is a trademark filed by OncoBeta International GmbH on February 12, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

OncoBeta International GmbH (9 trademarks)

Banneggstr. 57

Entity Type: 03

Trademark Details

Filing Date

February 12, 2021

Registration Date

May 6, 2025

First Use Anywhere

December 1, 2024

First Use in Commerce

December 1, 2024

Published for Opposition

November 9, 2021

Goods & Services

Medical imaging services, particularly services in the field of radiologic and nuclear medicine; radiation therapy for the treatment of cancer, in particular skin cancer and for cosmetic use; preparing personalized radiopharmaceutical preparations for the treatment of cancer or cosmetic uses, namely, pharmaceutical compounding of 188-Rhenium containing preparations in the nature of sodium Re-188-perrhenate

Pharmaceutical preparations for medical purposes, namely, for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations for medical purposes, namely, for use in chemotherapy; radiopharmaceutical preparations for the treatment of cancer, namely, 188-Rhenium containing preparations in the nature of sodium Re-188-perrhenate; radiopharmaceutical preparations for use in nuclear medicine; pharmaceutical preparations for use in brachytherapy and epidermal radionuclide treatment; radiopharmaceutical preparations for the treatment of skin cancer and skin lesions; radiopharmaceutical preparations for the use in cosmetic dermatology procedures

Preparing personalized radiopharmaceutical preparations for the treatment of cancer or cosmetic uses, namely, custom manufacture of 188-Rhenium containing preparations in the nature of sodium Re-188-perrhenate by a pharmaceutical compounder

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 25, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 25, 2026 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 25, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 25, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 25, 2026 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 6, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 17, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 17, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 7, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 7, 2025 AITU
USE AMENDMENT FILED
Jan 6, 2025 IUAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 6, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 6, 2025 REAP
TEAS STATEMENT OF USE RECEIVED
Dec 30, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jun 18, 2024 EX4G
SOU EXTENSION 4 FILED
Jun 18, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 18, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 26, 2023 EXRA
SOU EXTENSION 3 GRANTED
Dec 22, 2023 EX3G
SOU EXTENSION 3 FILED
Dec 22, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 27, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jun 25, 2023 EX2G
SOU EXTENSION 2 FILED
Jun 25, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 25, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 8, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 6, 2022 EX1G
SOU EXTENSION 1 FILED
Dec 6, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 6, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 28, 2022 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 19, 2022 ETOP
ASSIGNED TO EXAMINER
May 17, 2022 DOCK
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 6, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 1, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 17, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 17, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 17, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 17, 2021 CNEA
ASSIGNED TO EXAMINER
Sep 9, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 17, 2021 NWOS
NEW APPLICATION ENTERED
Feb 16, 2021 NWAP